Funding Received
$23.3 Million in 2 Rounds from 4 Investors
Most Recent Funding
$19 Million Series B on July 8, 2011
Headquarters:
Boston, MA
Description:
SpringLeaf Therapeutics develops drug delivery technologies.
Founders:
Michael Cima
Categories:
Biotechnology
Website:
http://www.springleaftx.com

Company Details

Update

SpringLeaf Therapeutics (formerly known as Entra Pharmaceuticals, Inc.) is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.

Current Team (3)

Update

Past Team (2)

Update

Funding Rounds (2) - $19M

Update

Board Members and Advisors (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    8 St. Mary's Street

    Suite 601

    Boston, MA 02215

    USA

Images (1)

Update
  • 3faf39f732e6cd0e16f53b1b697d3220